Ear-Zapping device could help kidney Patients' hearts

NCT ID NCT05981183

Recruiting now Knowledge-focused Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study is testing whether a device that gently stimulates a nerve in the ear is safe and tolerable for people with chronic kidney disease (CKD). Twenty adults with moderate to advanced CKD will use the device for 15 minutes. Researchers will measure heart rate changes and blood pressure to see if the device might help reduce heart risks in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: transcutaneous auricular vagus nerve stimulation device (TENS unit)
What this could lead to: If this pilot shows promise, it could lead to a larger study testing whether nerve stimulation can reduce heart-related risks in people with chronic kidney disease.
What could go wrong: This is a very early, small pilot study with only 20 participants. It is designed to test feasibility and safety, not to prove the treatment works. The device may have no meaningful effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE

Contacts and locations

Locations

NYU Langone Health
RECRUITING

New York, New York, 11215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.